(Q45848424)

16 December 2017

title

Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results (English)

1 reference

16 December 2017

1 reference

1 reference

5

1 reference

16 December 2017

David K. Shay

10

1 reference

16 December 2017

Edward A Belongia

1

object named as

Edward A Belongia

1 reference

16 December 2017

6

Jennifer K Meece

1 reference

16 December 2017

Mary F. Vandermause

7

object named as

Mary Vandermause

1 reference

16 December 2017

Burney A Kieke

2

object named as

Burney A Kieke

1 reference

16 December 2017

author name string

James G Donahue

3

1 reference

16 December 2017

Laura A Coleman

4

1 reference

16 December 2017

Stephen Lindstrom

8

1 reference

16 December 2017

Paul Gargiullo

9

1 reference

16 December 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

16 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

16 December 2017

volume

29

1 reference

16 December 2017

issue

38

1 reference

16 December 2017

page(s)

6558-6563

1 reference

16 December 2017

Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Comparative efficacy of inactivated and live attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Epidemiologic research in an integrated regional medical care system: The Marshfield Epidemiologic Study Area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Diarrhea incidence and farm-related risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Comparative study of nasopharyngeal aspirate and nasal swab specimens for detection of influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Estimability and estimation in case-referent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

What Does the Odds Ratio Estimate in a Case-Control Study?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Time lines of infection and disease in human influenza: a review of volunteer challenge studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Stochastic processes are key determinants of short-term evolution in influenza a virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.002

10.1016/J.VACCINE.2011.07.002

7 January 2021

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017